These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16442209)

  • 1. Prostate biopsy and optimization of cancer yield.
    Bostwick DG; Meiers I
    Eur Urol; 2006 Mar; 49(3):415-7. PubMed ID: 16442209
    [No Abstract]   [Full Text] [Related]  

  • 2. 2005 update on pathology of prostate biopsies with cancer.
    Montironi R; Vela-Navarrete R; Lopez-Beltran A; Mazzucchelli R; Bono A
    Eur Urol; 2006 Mar; 49(3):441-7. PubMed ID: 16413665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
    Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
    Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate biopsy.
    Wood DP
    J Urol; 2001 May; 165(5):1560-1. PubMed ID: 11342917
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostatic punch biopsy].
    Braun M; Engelmann U
    Aktuelle Urol; 2006 Jul; 37(4):291-302. PubMed ID: 16897646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of prostate cancer].
    Seitz M; Stanislaus P; Stief C
    MMW Fortschr Med; 2008 Jul; 150(28-31):39-41, 43. PubMed ID: 19006891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Predictive value of serum PSA in detection of prostate cancer by fine needle biopsy].
    Pozharisskiĭ KM; Arzumanov AA; Kudaĭbergenova AG; Ovchinnikov IV; Leonenkov RV
    Vopr Onkol; 2008; 54(3):324-7. PubMed ID: 18652237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of prostate cancer: yes or no?].
    Van Cangh PJ
    Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosing prostate cancer - what GPs need to know.
    Frydenberg M; Wijesinha S
    Aust Fam Physician; 2007 May; 36(5):345-7. PubMed ID: 17492070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the pathologist in diagnosing prostate cancer and guiding therapy.
    Weinstein MH
    N C Med J; 2006; 67(2):140-5. PubMed ID: 16752719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative tumor board: recently diagnosed prostate cancer.
    Schacht MJ; Saxe GA; Bauer-Wu S; Kennedy S; Monti DA; Peterson C; Rosenberg Z; Block KI
    Integr Cancer Ther; 2003 Mar; 2(1):63-90. PubMed ID: 12941168
    [No Abstract]   [Full Text] [Related]  

  • 13. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen best practice statement: 2009 update.
    Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
    Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
    Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.
    Elliott CS; Shinghal R; Presti JC
    J Urol; 2008 May; 179(5):1756-61; discussion 1761. PubMed ID: 18343425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA tests. The latest developments.
    Mayo Clin Health Lett; 2009 Jan; 27(1):6. PubMed ID: 19180757
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing risk: does this patient have prostate cancer?
    Carter HB
    J Natl Cancer Inst; 2006 Apr; 98(8):506-7. PubMed ID: 16622114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.